Azithromycin Cas numero: 83905-01-5 Inzira ya molekulari : C38H72N2O12

Ibicuruzwa

Azithromycin Cas numero: 83905-01-5 Inzira ya molekulari : C38H72N2O12

Ibisobanuro bigufi:

Numero ya Cas: 83905-01-5

Izina ryimiti : Azithromycin

Inzira ya molekulari : C38H72N2O12

Synonyme : (2R, 3S, 4R, 5R, 8R, 10R, 11R, 12S, 13S, 14R) -13 - [(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L- ribo-hexopyranosyl) oxy] -2-Ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11 - [[3,4,6-trideoxy-3- ( dimethylamino) -β-D-xylo-hexopyranosyl] oxy] -1-oxa-6-azacyclopentadecan-15-imwe


Ibicuruzwa birambuye

Ibicuruzwa

Ibicuruzwa byihariye

Ingingo yo gushonga 115° C.
Ubucucike 1.18 g / cm³
ububiko bwa temp Ikirere cyinjiza, Ubushyuhe bwicyumba 2-8 ° C.
gukemura DMF: 16 ​​mg / ml DMSO: 5 mg / mlm Ethanol: 16 mg / ml Ethanol: PBS (pH 7.2) (1: 1): 0,50 mg / ml
ibikorwa byiza  N / A.
Kugaragara Ifu yera
Isuku ≥98%

Ibisobanuro

Manus Aktteva Biopharma LLP, isosiyete ikora amasoko ku isi kandi itanga Azithromycin (CAS No.: 83905-01-5) itanga ibyifuzo byawe bya RND / Iterambere ryinshi cyangwa iyamamaza, ukurikije uko ibicuruzwa bimeze.

IKIBAZO: Mugihe umwete wose ushoboka uzakorwa kandi tuzafatanya mubibazo byose niba hari ikibazo kivutse mugihe cyamasoko, ntidushobora kuryozwa kutubahiriza cyangwa ibibazo byose mubikorwa bishobora kubaho, bitarenze ubushobozi bwacu. Ibicuruzwa bigwa mu byiciro bigenzurwa / urutonde rwibiyobyabwenge bigomba koherezwa mu mahanga biturutse ku bayobozi b’ibikorwa gusa birwanya gusa uruhushya rwatumijwe mu mahanga rwatanzwe n’inzego zibishinzwe z’ibihugu bitumiza mu mahanga. amategeko mu karere cyangwa ku isi yose.Inyandiko zacu rusange zivuga ibyiringiro byacu.Ntabwo dushishikarizwa cyangwa ngo dushake kuba bamwe mu bigo byigenga cyangwa ibya leta kugirango tugaragaze ko twubahiriza.

PATENTS Ibicuruzwa bikingiwe na patenti byemewe ntibishobora kugurishwa mubihugu aho kugurisha ibicuruzwa nkibi bibangamiye ipatanti kandi inshingano zayo zikaba zibangamira abaguzi.Ibicuruzwa kuri ubu byemewe na Patente yemewe yo muri Amerika bitangwa kugirango bikoreshe R&D hakurikijwe 35 USC 271 + A13 (1) • Manus Aktteva Biopharma LLP nta nshingano / inshingano iyo ihabwa ibicuruzwa bibangamira umutungo bwite wubwenge muburyo ubwo aribwo bwose burimo uburenganzira bw'ipatanti ku muntu uwo ari we wese.Manus Aktteva Biopharma LLP ntigaragaza cyangwa garanti y'ubwoko ubwo aribwo bwose, bwerekana cyangwa bwerekana, kubyerekeye umwimerere cyangwa kwiringirwa kubijyanye n'umutungo wubwenge urimo patenti mubicuruzwa cyangwa serivisi kubintu byose.Manus Aktteva Biopharma LLP iraburira abagurisha kutagurisha ibicuruzwa byose bibangamira umutungo bwite wubwenge muburyo ubwo aribwo bwose burimo uburenganzira bwa patenti kumuntu uwo ariwe wese.Manus Aktteva Biopharma LLP iraburira abaguzi kudakoresha / kugura ibicuruzwa ibyo aribyo byose kugirango bagere ku bicuruzwa bishobora kuba bitera nkana guhungabanya umutungo w’ubwenge mu buryo ubwo aribwo bwose burimo uburenganzira bw’ipatanti ku muntu uwo ari we wese.

imikoreshereze na dosiye

Azithromycine ni kimwe cya kabiri, cyongerewe impeta ya erythromycine ikorwa na Beckmann yongeye guhinduranya okisime ya erythromycine no kugabanuka kuri imine ether, ikurikirwa na methylation reductive.Azithromycin yari iyambere muri azide kandi yashizweho kugirango itezimbere ituze hamwe nubuzima bwa kimwe cya kabiri cya erythromycine A, ndetse no kunoza ibikorwa birwanya bagiteri mbi ya Gram.Kuva yavumburwa mu 1980 na Djokic hamwe nabakozi mukorana, azithromycin yishimiye ubuvuzi bwiza.

CADEB

  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze